FHTX
Foghorn Therapeutics Inc
NASDAQ: FHTX · HEALTHCARE · BIOTECHNOLOGY
$4.17
-8.68% today
Updated 2026-06-02
Market cap
$219.00M
P/E ratio
—
P/S ratio
7.76x
EPS (TTM)
$-1.17
Dividend yield
—
52W range
$3 – $7
Volume
0.1M
Foghorn Therapeutics Inc (FHTX) Insider transactions
Net insider activity
Net buying (14,299,891 shares)
Buy transactions
82
Sell transactions
18
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-10 | GOTTSCHALK, ADRIAN | Director, Chief Executive Officer | Buy | 59,208 | — | — |
| 2026-04-09 | GOTTSCHALK, ADRIAN | Director, Chief Executive Officer | Buy | 47,497 | — | — |
| 2026-02-23 | MAYNARD, RYAN D | Chief Financial Officer | Buy | 400,000 | $5.75 | $2.30M |
| 2026-02-05 | GOTTSCHALK, ADRIAN | Director, Chief Executive Officer | Buy | 1,075,000 | $5.23 | $5.62M |
| 2026-01-30 | RIVKIN, ANNA | Chief Business Officer | Buy | 165,000 | $5.71 | $942150.00 |
| 2026-01-30 | LACASCIA, MICHAEL | Chief Legal Officer | Buy | 295,000 | $5.71 | $1.68M |
| 2026-01-30 | COSTA, CARLOS | Chief People Officer | Buy | 230,000 | $5.71 | $1.31M |
| 2026-01-30 | CARDAMA, ALFONSO QUINTAS | Chief Medical Officer | Buy | 300,000 | $5.71 | $1.71M |
| 2026-01-30 | BELLON, STEVEN F. | Chief Scientific Officer | Buy | 300,000 | $5.71 | $1.71M |
| 2026-01-13 | FLAGSHIP, PIONEERING, LLC | Director, 10% Owner | Buy | 1,117,734 | — | — |
| 2026-01-13 | FLAGSHIP, PIONEERING, LLC | Director, 10% Owner | Buy | 1,117,734 | — | — |
| 2026-01-13 | FLAGSHIP, PIONEERING, LLC | Director, 10% Owner | Buy | 2,235,468 | $6.71 | $15.00M |
| 2025-06-17 | SMITH, IAN F | Director | Buy | 25,000 | $4.79 | $119750.00 |
| 2025-06-17 | PARSHALL, B LYNNE | Director | Buy | 25,000 | $4.79 | $119750.00 |
| 2025-06-17 | MENDELSOHN, MICHAEL | Director | Buy | 25,000 | $4.79 | $119750.00 |
| 2025-06-17 | LYNCH, THOMAS J. JR. | Director | Buy | 25,000 | $4.79 | $119750.00 |
| 2025-06-17 | GILL, SIMBA | Director | Buy | 25,000 | $4.79 | $119750.00 |
| 2025-06-17 | COLE, DOUGLAS G. | Director | Buy | 25,000 | $4.79 | $119750.00 |
| 2025-06-17 | BILLER, SCOTT | Director | Buy | 25,000 | $4.79 | $119750.00 |
| 2025-05-01 | GALLAGHER, NEIL | Director | Buy | 50,000 | $4.16 | $208000.00 |
| 2025-05-01 | DUTY, STUART | Director | Buy | 50,000 | $4.16 | $208000.00 |
| 2025-04-25 | GOTTSCHALK, ADRIAN | Director, Chief Executive Officer | Buy | 300,000 | — | — |
| 2025-04-09 | GOTTSCHALK, ADRIAN | Director, Chief Executive Officer | Sale | 197,906 | — | — |
| 2025-01-22 | RIVKIN, ANNA | Chief Business Officer | Buy | 50,000 | $4.37 | $218500.00 |
| 2025-01-22 | LACASCIA, MICHAEL | Chief Legal Officer | Buy | 126,000 | $4.37 | $550620.00 |
| 2025-01-22 | HUMER, KRISTIAN | Chief Financial Officer | Buy | 120,000 | $4.37 | $524400.00 |
| 2025-01-22 | GOTTSCHALK, ADRIAN | Director, Chief Executive Officer | Buy | 400,000 | $4.37 | $1.75M |
| 2025-01-22 | COSTA, CARLOS | Chief People Officer | Buy | 115,000 | $4.37 | $502550.00 |
| 2025-01-22 | CARDAMA, ALFONSO QUINTAS | Chief Medical Officer | Buy | 125,000 | $4.37 | $546250.00 |
| 2025-01-22 | BELLON, STEVEN F. | Chief Scientific Officer | Buy | 140,000 | $4.37 | $611800.00 |
| 2024-09-23 | COSTA, CARLOS | Chief People Officer | Sale | 857 | — | — |
| 2024-09-23 | COSTA, CARLOS | Chief People Officer | Buy | 857 | $3.72 | $3188.04 |
| 2024-09-20 | COSTA, CARLOS | Chief People Officer | Sale | 35,756 | — | — |
| 2024-09-20 | COSTA, CARLOS | Chief People Officer | Sale | 35,756 | $10.04 | $358990.24 |
| 2024-09-18 | COSTA, CARLOS | Chief People Officer | Sale | 11,574 | — | — |
| 2024-09-18 | COSTA, CARLOS | Chief People Officer | Buy | 11,574 | $3.72 | $43055.28 |
| 2024-09-17 | COSTA, CARLOS | Chief People Officer | Sale | 10,272 | — | — |
| 2024-09-17 | COSTA, CARLOS | Chief People Officer | Sale | 10,272 | $10.04 | $103130.88 |
| 2024-09-16 | COSTA, CARLOS | Chief People Officer | Sale | 400 | — | — |
| 2024-09-16 | COSTA, CARLOS | Chief People Officer | Buy | 400 | $3.72 | $1488.00 |
| 2024-09-09 | BELLON, STEVEN F. | Chief Scientific Officer | Sale | 20,000 | $9.50 | $190000.00 |
| 2024-09-03 | RIVKIN, ANNA | Chief Business Officer | Buy | 190,000 | $7.85 | $1.49M |
| 2024-06-26 | SMITH, IAN F | Director | Buy | 16,000 | $5.52 | $88320.00 |
| 2024-06-26 | PARSHALL, B LYNNE | Director | Buy | 16,000 | $5.52 | $88320.00 |
| 2024-06-26 | MENDELSOHN, MICHAEL | Director | Buy | 16,000 | $5.52 | $88320.00 |
| 2024-06-26 | LYNCH, THOMAS J. JR. | Director | Buy | 16,000 | $5.52 | $88320.00 |
| 2024-06-26 | KOPPEL, ADAM | Director | Buy | 16,000 | $5.52 | $88320.00 |
| 2024-06-26 | GILL, SIMBA | Director | Buy | 16,000 | $5.52 | $88320.00 |
| 2024-06-26 | COLE, DOUGLAS G. | Director | Buy | 16,000 | $5.52 | $88320.00 |
| 2024-06-26 | BILLER, SCOTT | Director | Buy | 16,000 | $5.52 | $88320.00 |
| 2024-05-22 | FLAGSHIP, PIONEERING INC. | 10% Owner | Buy | 1,814,915 | $5.51 | $10.00M |
| 2024-05-22 | FLAGSHIP, PIONEERING INC. | 10% Owner | Buy | 1,814,914 | $5.51 | $10.00M |
| 2024-04-16 | HUMER, KRISTIAN | Chief Financial Officer | Buy | 275,000 | $6.03 | $1.66M |
| 2024-03-11 | CAVALIE, FANNY | Chief Strategy/Bus Ops Officer | Sale | 11,000 | $6.56 | $72133.60 |
| 2024-01-24 | LACASCIA, MICHAEL | Chief Legal Officer | Buy | 100,000 | $3.06 | $306000.00 |
| 2024-01-24 | GOTTSCHALK, ADRIAN | Director, Chief Executive Officer | Buy | 300,000 | $3.06 | $918000.00 |
| 2024-01-24 | COSTA, CARLOS | Chief People Officer | Buy | 90,000 | $3.06 | $275400.00 |
| 2024-01-24 | CAVALIE, FANNY | Chief Strategy/Bus Ops Officer | Buy | 80,000 | $3.06 | $244800.00 |
| 2024-01-24 | CARDAMA, ALFONSO QUINTAS | Chief Medical Officer | Buy | 60,000 | $3.06 | $183600.00 |
| 2024-01-24 | BELLON, STEVEN F. | Chief Scientific Officer | Buy | 110,000 | $3.06 | $336600.00 |
| 2023-12-08 | SMITH, IAN F | Director | Buy | 26,977 | — | — |
| 2023-09-11 | CARDAMA, ALFONSO QUINTAS | Chief Medical Officer | Buy | 272,000 | $7.57 | $2.06M |
| 2023-08-17 | GOTTSCHALK, ADRIAN | Director, Chief Executive Officer | Buy | 63,000 | — | — |
| 2023-08-16 | AGRESTA, SAMUEL | Chief Medical Officer | Sale | 311,297 | — | — |
| 2023-08-16 | AGRESTA, SAMUEL | Chief Medical Officer | Sale | 311,297 | $8.25 | $2.57M |
| 2023-06-21 | SMITH, IAN F | Director | Buy | 16,000 | — | — |
| 2023-06-21 | PARSHALL, B LYNNE | Director | Buy | 16,000 | — | — |
| 2023-06-21 | MENDELSOHN, MICHAEL | Director | Buy | 16,000 | — | — |
| 2023-06-21 | LYNCH, THOMAS J. JR. | Director | Buy | 16,000 | — | — |
| 2023-06-21 | KOPPEL, ADAM | Director | Buy | 16,000 | — | — |
| 2023-06-21 | GILL, SIMBA | Director | Buy | 16,000 | — | — |
| 2023-06-21 | COLE, DOUGLAS G. | Director | Buy | 16,000 | — | — |
| 2023-06-21 | BILLER, SCOTT | Director | Buy | 16,000 | — | — |
| 2023-05-26 | GOTTSCHALK, ADRIAN | Director, Chief Executive Officer | Sale | 300,000 | — | — |
| 2023-02-17 | GOTTSCHALK, ADRIAN | Director, Chief Executive Officer | Buy | 184,939 | — | — |
| 2023-02-17 | GOTTSCHALK, ADRIAN | Director, Chief Executive Officer | Buy | 4,371 | — | — |
| 2023-01-26 | REINE, ALLAN | Chief Financial Officer | Buy | 90,000 | — | — |
| 2023-01-26 | LACASCIA, MICHAEL | Chief Legal Officer | Buy | 90,000 | — | — |
| 2023-01-26 | GOTTSCHALK, ADRIAN | Director, Chief Executive Officer | Buy | 280,000 | — | — |
| 2023-01-26 | COSTA, CARLOS | Chief People Officer | Buy | 65,000 | — | — |
| 2023-01-26 | CAVALIE, FANNY | Chief Strategy/Bus Ops Officer | Buy | 65,000 | — | — |
| 2023-01-26 | BELLON, STEVEN F. | Chief Scientific Officer | Buy | 100,000 | — | — |
| 2023-01-26 | AGRESTA, SAMUEL | Chief Medical Officer | Buy | 60,000 | — | — |
| 2022-10-27 | LYNCH, THOMAS J. JR. | Director | Buy | 32,000 | $8.23 | $263360.00 |
| 2022-10-25 | GOTTSCHALK, ADRIAN | Director, Chief Executive Officer | Sale | 4,371 | — | — |
| 2022-09-16 | GOTTSCHALK, ADRIAN | Director, Chief Executive Officer | Sale | 40,000 | — | — |
| 2022-09-16 | GOTTSCHALK, ADRIAN | Director, Chief Executive Officer | Buy | 40,000 | $0.54 | $21600.00 |
| 2022-09-13 | GILL, SIMBA | Director | Sale | 47,939 | — | — |
| 2022-09-12 | GILL, SIMBA | Director | Sale | 82,000 | — | — |
| 2022-09-12 | GILL, SIMBA | Director | Buy | 82,000 | $0.73 | $59860.00 |
| 2022-08-16 | PARSHALL, B LYNNE | Director | Buy | 32,000 | $16.34 | $522880.00 |
| 2022-08-11 | BELLON, STEVEN F. | Chief Scientific Officer | Sale | 1,858 | — | — |
| 2022-08-11 | BELLON, STEVEN F. | Chief Scientific Officer | Buy | 1,858 | $3.72 | $6911.76 |
| 2022-08-01 | COSTA, CARLOS | Chief People Officer | Buy | 50,000 | — | — |
| 2022-06-21 | SMITH, IAN F | Director | Buy | 16,000 | — | — |
| 2022-06-21 | MENDELSOHN, MICHAEL | Director | Buy | 16,000 | — | — |
| 2022-06-21 | KOPPEL, ADAM | Director | Buy | 16,000 | — | — |
| 2022-06-21 | KADOCH, CIGALL | Director, 10% Owner | Buy | 16,000 | — | — |
| 2022-06-21 | GILL, SIMBA | Director | Buy | 16,000 | — | — |
| 2022-06-21 | COLE, DOUGLAS G. | Director | Buy | 16,000 | — | — |
Frequently asked questions
Are FHTX insiders buying or selling?
Over the transactions on record, FHTX insiders have been net buyers, with about $3.29M in stock sold across 18 sales, against 51 open-market purchases.
Does insider selling at FHTX mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which FHTX insiders are selling the most?
Recent selling is concentrated in a few names. AGRESTA, SAMUEL accounts for the largest share on record, with about $2.57M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.